Correspondence 0001140361-22-043945 from Disc Medicine, Inc. (IRON) (CIK 0001816736) (IRON)

Disc Medicine, Inc. (IRON) (CIK 0001816736)
Date: Dec. 1, 2022 · CIK: 0001816736 · Accession: 0001140361-22-043945

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-267276

Date

December 1, 2022

Author

Not clearly detected

Form

CORRESP

Company

Disc Medicine, Inc. (IRON) (CIK 0001816736)

Letter

Gemini Therapeutics, Inc.

297 Boston Post Road #248

Wayland, MA 01778

December 1, 2022

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:

Jessica Ansart

Abby Adams

Tara Harkins

Brian Cascio

Re:

Gemini Therapeutics, Inc.

Registration Statement on Form S-4

File No. 333-267276

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Gemini Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-4 (File No. 333-267276), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on December 2, 2022, or as soon thereafter as practicable.

Very truly yours,
GEMINI THERAPEUTICS, INC.

Show Raw Text

CORRESP
1
filename1.htm

    Gemini Therapeutics, Inc.

    297 Boston Post Road #248

    Wayland, MA 01778

    December 1, 2022

    VIA EDGAR

    Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Washington, D.C. 20549

            Attention:

            Jessica Ansart

            Abby Adams

            Tara Harkins

            Brian Cascio

            Re:

            Gemini Therapeutics, Inc.

            Registration Statement on Form S-4

            File No. 333-267276

            Request for Acceleration

    Ladies and Gentlemen:

    Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Gemini Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-4 (File No. 333-267276), as
      amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on December 2, 2022, or as soon thereafter as practicable.

            Very truly yours,

            GEMINI THERAPEUTICS, INC.

            By:

            /s/ Georges Gemayel

            Name:

            Georges Gemayel

            Title:

            Interim President and Chief Executive Officer

SecProbe.io